Anatomic Pathology Market Outlook (2022-2030)

[290 Pages Report] The global anatomic pathology market size reached a valuation of US$ 32.5 Billion in 2022 and is likely to grow at a robust CAGR of 8.2% between 2022 and 2030, surpassing US$ 61.1 Billion by the end of 2030. Growth in the global anatomic pathology market is driven by the rising application of anatomic pathology in disease diagnosis and drug discovery and development.

Attribute Details
Anatomic Pathology Market Size (2022) US$ 32.5 Billion
Anatomic Pathology Market Revenue Forecast (2030) US$ 61.1 Billion
Anatomic Pathology Market Growth Rate (2022 to 2030) 8.2% CAGR
North America Market Share 37.1%

Anatomic pathology is a medical specialty that focuses on identifying diseases based on microscopic, macroscopic, immunologic, biochemical, and molecular examinations of organs and tissues. Its (anatomical pathology) main role is to identify abnormalities that can help to diagnose disease and manage treatment.

The adoption of anatomic pathology has shown promising results in identifying and managing various types of tumors or cancers, kidney and liver diseases, autoimmune disorders, etc. As a result, it is often being used in end-use verticals such as hospitals, research laboratories, and diagnostic laboratories.

The rising prevalence of numerous diseases coupled with the growing need for early detection of chronic diseases and the rapidly expanding healthcare industry is providing a strong thrust to the growth of the anatomic pathology market and the trend is likely to continue during the forecast period.

Consequently, increasing usage of biomarkers advances in histology, and rapid expansion of the cellular pathology market will positively impact the anatomic pathology market projections in the future. Over the years, biomarkers have become quite popular as they allow pathologists to determine disease causation at the molecular level, which aids clinical decision-making and improves patient outcomes.

Currently, anatomic pathology accounts for a 0.2% share of the global pathology market and this number is expected to increase substantially on account of rising applications of anatomic pathology in numerous applications.

Regionally, North America will continue to dominate the global anatomic pathology market, accounting for around 37.1% share through 2030. Growth in the North American anatomic pathology market is driven by the strong presence of major market players, favorable government policies connected to pathological training programs, availability of advanced technologies, favorable reimbursement scenarios for anatomic pathology diagnostic tests, and rising healthcare expenditures

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 8.21%
H1, 2022 Projected 8.20%
H1, 2022 Outlook 7.80%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 40 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 41 ↓

The comparative analysis and market growth rate of global anatomic pathology market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 40 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 41 Basis Point Share (BPS).

The key developments in the market include the design of Biophotonics in pathology to describe various types of imaging methods available. This factor has enforced the factor of pathology and radiology to converge towards a more holistic approach to diagnostic imaging, thus playing as a major driving factor for growth of the market.

The market observes a decline in the BPS values owed to the decreased flexibility in work force staffing, when compared with general service providers such as laboratories, high operational costs and overheads with each unit of subspecialty operating, and a greater need for trained staff, among others.

Several new approaches, such as cryoelectron tomography, holographic tissue dynamics spectroscopy, cellular magnetic resonance imaging, exotic material lensing, and photoacoustic tomography are further set to propel the market growth over the coming years.

Anatomic Pathology Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)

The global demand for anatomic pathology products and services is projected to grow at a healthy CAGR of 8.2% during the forecast period between 2022 and 2030, totaling over US$ 61.1 Billion by 2030. Factors such as the rising prevalence of cancer and other target diseases, growing demand for personalized medicine, escalating need for early diagnosis of chronic diseases, surge in R&D activities, and introduction of favorable reimbursement policies are driving the anatomic pathology industry growth.

Anatomic pathology has become one of the most commonly used techniques for the detection and management of diseases like cancer. It allows pathologists to determine the cause and effect of particular diseases by analyzing tissues and organs during biopsies and other medical procedures.

The rapid surge in cancer cases across the globe is providing a major impetus to the growth of the anatomic pathology market and the trend is likely to continue during the forecast period. According to the American Cancer Society, it is estimated that the global cancer burden is expected to grow to 27.5 billion new cancer cases and 16.3 million cancer deaths by 2040. This will create immense demands for advanced diagnostic technologies and treatment approaches, thereby expanding the anatomic pathology market size.

Furthermore, advancements in anatomic pathology instruments will significantly aid in improving the anatomic pathology market share during the forecast period. Leading anatomic pathology manufacturers are continuously focusing on introducing advanced digital products such as specimen tracking systems (STS), to empower anatomical pathologists to accurately diagnose diseases and make confident treatment decisions.

Additionally, growing awareness, increasing healthcare expenditure, escalating cancer research, and a rise in the use of biomarkers during illness diagnosis will boost the anatomic pathology market growth during the forthcoming years.

Based on the aforementioned factors, FMI’s latest report on the anatomic pathology market forecasts the global anatomic pathology market to expand at 1.88X by 2030.

Anatomic Pathology Market

Which Factors are Challenging the Growth of Anatomic Pathology Market?

Despite its optimistic stance, the global anatomic pathology market is facing various obstacles that are challenging its growth to some extent. Some of these obstacles include the availability of refurbished anatomic pathology equipment, frequent product recalls, and the adoption of alternative diagnostic techniques.

Today, various refurbished anatomic pathology devices such as tissue processors, microtomes, and staining systems are available from LabX (US), Rankin Biomedical Corporation (US), Swerdlick Medical Systems (US), and AL-TAR (US). The availability of these refreshed anatomic pathology products is expected to negatively impact the revenue of companies selling branded anatomic pathology devices.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Analysis

How is the Growth Projection for the U.S. Anatomic Pathology Market?

“Rising Investments in Research and Development Creating Space for Anatomic Pathology Market Growth in the U.S.”

As per FMI, the U.S. is expected to account for a significant share of the global anatomic pathology market through 2030, owing to the rising prevalence of cancer, high research, and development funding, availability of favorable reimbursement policies, increasing adoption of pathology imaging systems, surge in anatomic pathology labs, flourishing human anatomical models market, and strong presence of leading anatomic pathology m market players.

Over the years, the U.S. has become a global leader in medical research. The country annually spends billions of dollars on research and development to advance personalized medicine and reduce the burden of chronic diseases. For instance, the National Institutes of Health (NIH) alone spends about US$ 41.7 billion annually on medical research for the American people.

Similarly, a rise in the number of new anatomic pathology product launches and approvals will improve the anatomic pathology market share of the U.S. during the forecast period.

How Will Growth Unfold in the German anatomic Pathology Market?

“Availability of Advanced Pathology Devices and Increasing Number of Anatomic Pathology Service Providers Spurring Growth in the Germany Anatomic Pathology Market”

With the rising prevalence of chronic diseases and the availability of advanced pathology devices, the anatomic pathology market in Germany is expected to grow at a strong CAGR during the forecast period between 2022 and 2030.

As the burden of cancer and other chronic diseases across Germany continues to rise, medical institutes and government organizations are putting various efforts to tackle the situation. They are increasingly investing in advanced diagnostic technologies to improve diagnostic screening and reduce healthcare burden. This is creating a conducive environment for the anatomic pathology industry growth in the country.

The European anatomic pathology market, spearheaded by Germany and the U.K. is expected to account for 25.7% of the global market share.

Category-wise Analysis

Based on Product and Service, Which Segment Accounts for the Largest Share of Anatomic Pathology market?

“Demand for Anatomic Pathology Services to Remain High Throughout the Forecast Period”

As per FMI, the anatomic pathology services segment is likely to account for the largest share of the global anatomic pathology market during the forecast period, owing to the rapid surge in cancer cases, availability of favorable reimbursement for diagnostic tests, and increase in the number of anatomic pathology service providers worldwide.

Which is the Most Lucrative Application of Anatomic Pathology?

“Disease Diagnosis Segment to Contribute Most to the Global Anatomic Pathology Market”

Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. Among these, the disease diagnosis segment accounted for the largest share in 2021, and is likely to grow at a relatively higher CAGR during the assessment period, as per the latest anatomic pathology market trends. This can be attributed to the rising incidence of cancer and other chronic diseases, the growing need for early diagnosis of these diseases to initiate proper treatment, and various initiatives launched by the government to facilitate diagnostic screening of chronic diseases.

Similarly, the expansion of the cancer tissue diagnostics market and advancements in tissue diagnostics will support the growth of this segment during the forthcoming years.

Which End User Segment Dominates the Global Anatomic Pathology Market?

“Demand for Anatomic Pathology Products and Services to Remain High in Hospitals”

Based on end users, the anatomic pathology market has been segmented into hospitals, research laboratories, diagnostic laboratories, and others. As per FMI, the hospital segment held the largest share of the anatomic pathology market in 2021 and the trend is likely to continue during the forecast period, owing to the rising number of patient visits to hospitals, growing awareness among people regarding the importance of early diseases diagnosis, and rapid increase in the number of hospitals worldwide.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Who are Some of the Leading Players in Anatomic Pathology Market?

Some of the leading anatomic pathology providers include Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics, Bio SB, and Agilent Technologies.

Players like Roche have become global leaders in solutions for anatomical pathology labs to diagnose cancers. They are continuously investing in research and development to advance personalized healthcare and integrate digital tools in anatomic pathology. For instance,

  • In 2021, Roche launched two new automated digital pathology algorithms called uPath HER2 image analysis and uPath HER2 Dual ISH image analysis, to support pathologists in making fast and accurate patient diagnoses in breast cancer.
  • In 2022, Roche collaborated with Bristol Myers Squibb to advance personalized healthcare through digital pathology solutions.

Similarly, various leading players are adopting strategies like new product launches, acquisitions, mergers, partnerships, and collaborations to gain a competitive edge in the global anatomic pathology market. For instance,

  • In 2021, Inform Diagnostics, a leading U.S. anatomic pathology provider, collaborated with Paige, a global leader in AI-based cancer diagnostics software for digital pathology, to integrate digital solutions with anatomic pathology diagnostics.
  • In June 2022, EmeritusDX acquired Freedom Pathology Partners to further expand its national presence in providing anatomic pathology, molecular testing, and fluorescence in situ hybridization.

Anatomic Pathology Industry Report Scope

Future Market Insights latest report provides a detailed anatomic pathology market forecast for a period of 8 years (2022-2030). It examines how advancement in anatomic pathology is revolutionizing the disease diagnosis and drug discovery services markets

The report is intended to enlighten customers with significant details about market shaping factors including drivers, restraints, emerging opportunities and latest anatomic pathology market trends.

While developed nations like the United States, Germany, and the United Kingdom remain at the top of the ladder, factors pushing anatomic pathology industry growth across emerging economies such as India and China have been thoroughly discussed.

FMI also illustrates how rise in chronic diseases and increasing investments in R&D will expand the global anatomic pathology market size during the forthcoming years. Besides this, it offers insights into leading anatomic pathology manufacturers and their growth strategies.

The Anatomic Pathology Market Analysis Includes:

  • An 8-year realistic sales forecast of anatomic pathology across several end use verticals
  • Insights into futuristic anatomic pathology market projections
  • Market dynamics including drivers, restraints, and emerging opportunities
  • Details about key players operating in anatomic pathology market and their respective growth strategies to penetrate attractive markets
  • Information about lucrative regional pockets and leading anatomic pathology market segments
  • Recent advances in anatomic pathology market
  • The winning imperatives in anatomic pathology market
  • Opportunity assessment
  • Pricing analysis

Scope of Report

Attribute Details
Forecast Period 2022 to 2030
Historic Data Available for 2015 to 2021
Market Analysis USD Billion for Value
Report Coverage Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives
Key Segments Covered

Product & Service, Application, End User, Region

Key regions covered

North America (USA, Canada, Rest of North America); Latin America (Brazil, Argentina, Mexico, Rest of Latin America); Western Europe (Germany, UK, France, Rest of Western Europe); Eastern Europe (Russia, Spain, Rest of Eastern Europe); South Asia Pacific (China, India, Japan, Malaysia, Thailand, Indonesia, South Korea, Rest of South Asia & Pacific); Middle East & Africa GCC Countries (Turkey, Israel, Rest of MEA); Rest of the World (Oceania, Africa, South America)

End User

Hospitals, Research Laboratories, Diagnostic Laboratories, Others

Key companies profiled Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Sakura Finetek USA; Inc.; F.Hoffmann-La Roche AG; Cardinal Health; Inc.; BioGenex; NeoGenomics; Bio SB; Agilent Technologies
Customization & pricing Available upon request

Key Segments of Anatomic Pathology Industry Survey

Anatomic Pathology Market by Product & Service:

  • Anatomic Pathology Instruments
  • Anatomic Pathology Consumables
  • Anatomic Pathology Services

Anatomic Pathology Market by Application:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Anatomic Pathology Market by End User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Anatomic Pathology Market by Region:

  • North America Anatomic Pathology Market
  • Latin America Anatomic Pathology Market
  • Europe Anatomic Pathology Market
  • East Asia Anatomic Pathology Market
  • South Asia & Pacific Anatomic Pathology Market
  • Middle East & Africa (MEA) Anatomic Pathology Market

Frequently Asked Questions

How big is the global anatomic pathology industry?

As per FMI, the global anatomic pathology market was valued at US$ 32.5 Billion in 2022.

What is the growth projection for anatomic pathology market?

The global anatomic pathology market is expected to grow at 8.2% CAGR during the forecast period between 2022 to 2030.

What is the projected valuation for anatomic pathology market?

The anatomic pathology market is projected to reach US$ 61.1 Billion by 2030.

Who are the leading players operating in anatomic pathology?

Laboratory Corporation of America Holdings, Sakura Finetek USA, Inc., BioGenex, Quest Diagnostics Incorporated, F.Hoffmann-La Roche AG, Cardinal Health, Inc., NeoGenomics, and Bio SB are some of the leading players operating in anatomic pathology market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Key Trends

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting The Market

4. Market Context

    4.1. Anatomic Pathology Market - Product Adoption / Usage Analysis, By Region

    4.2. Global Anatomic Pathology –  Key Promotional Strategies, By Manufacturers

    4.3. Anatomic Pathology Market: Cancer Epidemiology, By Region

    4.4. Anatomic Pathology Market Regulatory Scenario

5. COVID-19 Crisis Analysis

6. Market Background

    6.1. Macroeconomic Factors

    6.2. Demand Side Drivers

    6.3. Supply Side Driver

    6.4. Restraints

    6.5. Opportunities

7. Global Anatomic Pathology Market: Pricing Analysis

8. Global Anatomic Pathology Market Demand (in Value or Size in US$ Bn) Analysis 2015-2021 and Forecast, 2022–2030 

    8.1. Historical Market Value (US$ Bn) Analysis, 2015-2021

    8.2. Current and Future Market Value (US$ Bn) Projections, 2022-2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By Product

    9.1. Introduction / Key Findings

    9.2. Global Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    9.3. Global Anatomic Pathology Market Attractiveness Analysis 2022–2030, by Product and Services Type

10. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, Application

    10.1. Introduction / Key Findings

    10.2. Global Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    10.3. Global Anatomic Pathology Market Attractiveness Analysis 2022–2030, by Area of Application

11. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By End User

    11.1. Introduction / Key Findings

    11.2. Global Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User 

    11.3. Global Anatomic Pathology Market Attractiveness Analysis 2022–2030, by End User

12.  Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Bn) Analysis By Region, 2015 - 2019

    12.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2020 – 2030

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    13.1. Introduction

    13.2. North America Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    13.3. North America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    13.4. North America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    13.5. North America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    13.6. North America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    13.7. North America Anatomic Pathology Market Attractiveness Analysis, 2022–2030

14. Latin America Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    14.1. Introduction

    14.2. Latin America Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    14.3. Latin America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    14.4. Latin America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    14.5. Latin America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    14.6. Latin America Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    14.7. Latin America Anatomic Pathology Market Attractiveness Analysis, 2022–2030

15. Europe Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    15.1. Introduction

    15.2. Europe Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    15.3. Europe Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    15.4. Europe Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    15.5. Europe Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    15.6. Europe Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    15.7. Europe Anatomic Pathology Market Attractiveness Analysis, 2022–2030

16. South Asia Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    16.1. Introduction

    16.2. South Asia Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    16.3. South Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    16.4. South Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    16.5. South Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    16.6. South Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    16.7. South Asia Anatomic Pathology Market Attractiveness Analysis, 2022–2030

17. East Asia Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    17.1. Introduction

    17.2. East Asia Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    17.3. East Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    17.4. East Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    17.5. East Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    17.6. East Asia Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    17.7. East Asia Anatomic Pathology Market Attractiveness Analysis, 2022–2030

18. Oceania Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    18.1. Introduction

    18.2. Oceania Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    18.3. Oceania Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    18.4. Oceania Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    18.5. Oceania Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    18.6. Oceania Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    18.7. Oceania Anatomic Pathology Market Attractiveness Analysis, 2022–2030

19. Middle East and Africa (MEA) Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    19.1. Introduction

    19.2. MEA Anatomic Pathology Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2030

    19.3. MEA Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Country

    19.4. MEA Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Product and Services Type

    19.5. MEA Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By Area of Application

    19.6. MEA Anatomic Pathology Market Value (US$ Bn) Analysis and Forecast 2015–2030, By End User

    19.7. MEA Anatomic Pathology Market Attractiveness Analysis, 2022–2030

20. Key and Emerging Countries Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    20.1. USA Anatomic Pathology Market Analysis

        20.1.1. By Product & Services Type

        20.1.2. By Area of Application

        20.1.3. By End User

    20.2. Canada Anatomic Pathology Market Analysis

        20.2.1. By Product & Services Type

        20.2.2. By Area of Application

        20.2.3. By End User

    20.3. Brazil Anatomic Pathology Market Analysis

        20.3.1. By Product & Services Type

        20.3.2. By Area of Application

        20.3.3. By End User

    20.4. Mexico Anatomic Pathology Market Analysis

        20.4.1. By Product & Services Type

        20.4.2. By Area of Application

        20.4.3. By End User

    20.5. Argentina Anatomic Pathology Market Analysis

        20.5.1. By Product & Services Type

        20.5.2. By Area of Application

        20.5.3. By End User

    20.6. Germany Anatomic Pathology Market Analysis

        20.6.1. By Product & Services Type

        20.6.2. By Area of Application

        20.6.3. By End User

    20.7. UK Anatomic Pathology Market Analysis

        20.7.1. By Product & Services Type

        20.7.2. By Area of Application

        20.7.3. By End User

    20.8. France Anatomic Pathology Market Analysis

        20.8.1. By Product & Services Type

        20.8.2. By Area of Application

        20.8.3. By End User

    20.9. Italy Anatomic Pathology Market Analysis

        20.9.1. By Product & Services Type

        20.9.2. By Area of Application

        20.9.3. By End User

    20.10. Spain Anatomic Pathology Market Analysis

        20.10.1. By Product & Services Type

        20.10.2. By Area of Application

        20.10.3. By End User

    20.11. Russia Anatomic Pathology Market Analysis

        20.11.1. By Product & Services Type

        20.11.2. By Area of Application

        20.11.3. By End User

    20.12. China Anatomic Pathology Market Analysis

        20.12.1. By Product & Services Type

        20.12.2. By Area of Application

        20.12.3. By End User

    20.13. Japan Anatomic Pathology Market Analysis

        20.13.1. By Product & Services Type

        20.13.2. By Area of Application

        20.13.3. By End User

    20.14. South Korea Anatomic Pathology Market Analysis

        20.14.1. By Product & Services Type

        20.14.2. By Area of Application

        20.14.3. By End User

    20.15. India Anatomic Pathology Market Analysis

        20.15.1. By Product & Services Type

        20.15.2. By Area of Application

        20.15.3. By End User

    20.16. Thailand Anatomic Pathology Market Analysis

        20.16.1. By Product & Services Type

        20.16.2. By Area of Application

        20.16.3. By End User

    20.17. Indonesia Anatomic Pathology Market Analysis

        20.17.1. By Product & Services Type

        20.17.2. By Area of Application

        20.17.3. By End User

    20.18. Malaysia Anatomic Pathology Market Analysis

        20.18.1. By Product & Services Type

        20.18.2. By Area of Application

        20.18.3. By End User

    20.19. Australia Anatomic Pathology Market Analysis

        20.19.1. By Product & Services Type

        20.19.2. By Area of Application

        20.19.3. By End User

    20.20. New Zealand Anatomic Pathology Market Analysis

        20.20.1. By Product & Services Type

        20.20.2. By Area of Application

        20.20.3. By End User

    20.21. GCC Countries Anatomic Pathology Market Analysis

        20.21.1. By Product & Services Type

        20.21.2. By Area of Application

        20.21.3. By End User

    20.22. Turkey Anatomic Pathology Market Analysis

        20.22.1. By Product & Services Type

        20.22.2. By Area of Application

        20.22.3. By End User

    20.23. South Africa Anatomic Pathology Market Analysis

        20.23.1. By Product & Services Type

        20.23.2. By Area of Application

        20.23.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies 

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive (Tentative List)

        22.3.1. F. Hoffmann-La Roche Ltd

            22.3.1.1.  Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Key Financial

            22.3.1.4. Sales Footprint

            22.3.1.5. Analyst commentary

        22.3.2. Danaher Corporation 

        22.3.3. Hologic Inc. 

        22.3.4. Thermo Fisher Scientific, Inc.

        22.3.5. Agilent Technologies, Inc 

        22.3.6. NeoGenomics

        22.3.7. Cardinal Health, Inc

        22.3.8. Gestalt Diagnostics 

        22.3.9. Inspirata Inc 

        22.3.10. Laboratory Corporation of America Holdings 

        22.3.11. Nichirei Bioscience (Nichirei Corporation)

        22.3.12. BioGenex

23. Assumptions and Acronyms Used

24. Research Methodology

Recommendations

Healthcare

Digital Pathology Market

August 2021

REP-GB-124

October 2023

178 pages

Healthcare

Cellular Pathology Market

June 2018

REP-GB-6869

July 2023

258 pages

Healthcare

Quantitative Pathology Imaging Market

September 2017

REP-GB-5041

July 2022

333 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Anatomic Pathology Market